ClinicalTrials.Veeva

Menu

A Study of Intracellular Signaling in Muscle and Fat Cells During Ketosis

University of Aarhus logo

University of Aarhus

Status

Completed

Conditions

Diabetes Mellitus Type 1
Ketoacidosis

Treatments

Biological: LPS

Study type

Interventional

Funder types

Other

Identifiers

NCT02157155
1-10-72-98-14

Details and patient eligibility

About

Hypothesis

  1. To define whether stimulation of ATGL and suppression of G0/G1 switch gene occur in the initial phases of diabetic ketoacidosis and thus can be identified as the primary mechanisms behind this life threatening condition.
  2. Make a human model for studying ketoacidosis.

The investigators plan to reduce in their regular insulin over night. In the morning we administer endotoxin, which together with a relative lack of insulin will initiate ketogenesis - a state of ketoacidosis. On another occasion strict glycemic control is imposed by means of intravenous insulin. The testing is done two separate days with at least 3 weeks in between and patients are admitted to hospital the evening before the day of testing. The investigators use isotopic tracers to determine metabolic fluxes and analyse fat (ATGL, G0/G1 switch gene) and muscle biopsies.

Enrollment

9 patients

Sex

Male

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diabetes type 1
  • 19 < BMI < 26
  • minimal or negative C-peptide
  • written consent

Exclusion criteria

  • Severe comorbidity
  • regular medication apart from insulin

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

9 participants in 2 patient groups

Intervention
Experimental group
Description:
Insulin reduction and mimic infection with LPS
Treatment:
Biological: LPS
Control
No Intervention group
Description:
Normal insulin and no LPS

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems